Related Experiment Videos

Niacin prevents DNA strand breakage by adenosine deaminase inhibitors

A B Weitberg1, D Corvese

  • 1Division of Hematology/Oncology, Roger Williams General Hospital, Providence, Rhode Island 02908.

Insights

Adenosine deaminase inhibitors cause DNA strand breaks in human cells. Pre-treating cells with niacin, a NAD+ precursor, significantly reduced these breaks, suggesting a method to mitigate inhibitor toxicity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Adenosine deaminase (ADA) inhibitors, such as deoxycoformycin and EHNA, are used in certain therapeutic contexts.
  • These inhibitors are known to affect cellular processes, but their direct impact on DNA integrity requires further elucidation.
  • DNA damage and repair mechanisms are critical determinants of cellular response to xenobiotics.

Purpose of the Study:

  • To investigate the effect of ADA inhibitors deoxycoformycin and EHNA on DNA integrity in human lymphocytes.
  • To explore the role of poly(ADP-ribosylation) in response to ADA inhibitor-induced DNA damage.
  • To evaluate the potential protective effect of niacin, a NAD+ precursor, against ADA inhibitor-induced DNA strand breaks.

Main Methods:

  • Cultured human lymphocytes were treated with deoxycoformycin and EHNA.
  • Single-strand DNA breaks were quantified using established assays.
  • Cells were pre-incubated with niacin prior to exposure to ADA inhibitors to assess protective effects.

Main Results:

  • Deoxycoformycin significantly increased single-strand DNA breaks (4-fold) in lymphocytes.
  • EHNA induced DNA strand breaks in a dose-dependent manner.
  • Pre-incubation with niacin markedly reduced the incidence of strand breaks induced by both inhibitors.

Conclusions:

  • ADA inhibitors deoxycoformycin and EHNA induce significant single-strand DNA breaks in human lymphocytes.
  • Niacin administration can mitigate this DNA damage, likely by replenishing NAD+ required for DNA repair.
  • Niacin may serve as a protective agent against the genotoxic effects of ADA inhibitors.

Related Concept Videos